Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DR REDDYS LABORATORIES LTD Regulatory Filings 2023

Jul 20, 2023

30528_rns_2023-07-20_52518883-b4e3-441f-b900-e20350b0460a.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [453 x 112] intentionally omitted <==

July 20, 2023

National Stock Exchange of India Ltd. (Stock Code: DRREDDY-EQ) BSE Limited (Stock Code: 500124) New York Stock Exchange Inc. (Stock Code: RDY) NSE IFSC Ltd. (Stock Code: DRREDDY)

Dear Sirs,

Sub: Intimation

In furtherance to our earlier intimation dated March 31, 2021, this is to inform you that the National Company Law Tribunal, Mumbai vide its order dated June 22, 2023, the certified copy of which has been received on July 19, 2023, has approved the Scheme of Amalgamation for merger of Pharmasofttech Awacs Private Limited into Pharmarack Technologies Private Limited. Both these companies are subsidiaries of Aarogya Bharat Digital LLP (earlier known as DigiHealth Technologies LLP), which in turn is a wholly-owned subsidiary of ABCD Technologies LLP. The Company owns 6.45% interest in ABCD Technologies LLP.

Kindly take the above on your record.

Thanking you.

Yours faithfully, For Dr. Reddy’s Laboratories Limited

KUMAR Digitally signed by KUMAR RANDHI RANDHIR SINGH Date: 2023.07.20 R SINGH 23:35:17 +05'30'

K Randhir Singh

Company Secretary, Compliance Officer and Head CSR